Core Laboratories Inc.
CLB
$16.31
$0.201.24%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.63% | 24.98% | -25.31% | -14.38% | -36.46% |
| Total Depreciation and Amortization | -3.42% | -4.47% | -4.85% | -5.26% | -5.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -116.21% | -76.37% | 57.42% | 187.75% | 380.85% |
| Change in Net Operating Assets | -20.58% | 220.10% | 178.24% | 123.86% | 115.19% |
| Cash from Operations | -9.97% | 29.60% | 71.76% | 127.47% | 197.25% |
| Capital Expenditure | -34.57% | -23.95% | -18.66% | -23.15% | -15.40% |
| Sale of Property, Plant, and Equipment | 215.32% | 235.58% | 137.78% | 257.94% | -46.95% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.60% | 152.36% | 73.74% | 42.30% | 5.59% |
| Cash from Investing | 61.41% | 39.81% | 36.77% | 3.88% | -67.76% |
| Total Debt Issued | -16.00% | -58.41% | -77.60% | -78.22% | -80.92% |
| Total Debt Repaid | 24.72% | 52.03% | 62.26% | 61.14% | 66.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -571.27% | -346.60% | -224.45% | -140.96% | -8.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.11% | -0.21% | -0.37% | -0.43% | -0.48% |
| Other Financing Activities | 2.10% | 95.45% | 95.57% | 85.58% | 57.05% |
| Cash from Financing | 3.45% | 15.02% | -62.16% | -149.16% | -259.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.47% | 258.57% | 624.34% | 1,410.71% | 68.45% |